<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2015-12-01" updated="2019-12-02">
  <drugbank-id primary="true">DB10997</drugbank-id>
  <name>Autologous cultured chondrocytes</name>
  <description>Autologous cultured chrondrocytes are used as autologous cell therapy to repair articular cartilage injuries in the knee (femoral condyle) due to acute or repetitive trauma. It serves as an alternative repair treatment for patients with inadequate response to pre-existing surgical methods. The surgical implantation shows a tolerable safety profile and efficacy up to 4 years, but it is not indicated for patients with osteoarthritis. It has been used since 1995 as Carticel and gained biologic license in 1997. The surgical implantation was first performed in Sweden.</description>
  <cas-number/>
  <unii>D5P3K3V822</unii>
  <groups>
    <group>approved</group>
    <group>investigational</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A19154</ref-id>
        <pubmed-id>27349321</pubmed-id>
        <citation>Melrose J: The knee joint loose body as a source of viable autologous human chondrocytes. Eur J Histochem. 2016 Jun 10;60(2):2645. doi: 10.4081/ejh.2016.2645.</citation>
      </article>
      <article>
        <ref-id>A19155</ref-id>
        <pubmed-id>26987846</pubmed-id>
        <citation>Nazempour A, Van Wie BJ: Chondrocytes, Mesenchymal Stem Cells, and Their Combination in Articular Cartilage Regenerative Medicine. Ann Biomed Eng. 2016 May;44(5):1325-54. doi: 10.1007/s10439-016-1575-9. Epub 2016 Mar 17.</citation>
      </article>
      <article>
        <ref-id>A19156</ref-id>
        <pubmed-id>27347486</pubmed-id>
        <citation>Akkiraju H, Nohe A: Role of Chondrocytes in Cartilage Formation, Progression of Osteoarthritis and Cartilage Regeneration. J Dev Biol. 2015 Dec;3(4):177-192. Epub 2015 Dec 18.</citation>
      </article>
      <article>
        <ref-id>A19157</ref-id>
        <pubmed-id>8078550</pubmed-id>
        <citation>Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994 Oct 6;331(14):889-95.</citation>
      </article>
      <article>
        <ref-id>A19158</ref-id>
        <pubmed-id>26962464</pubmed-id>
        <citation>Zhang W, Ouyang H, Dass CR, Xu J: Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res. 2016 Mar 1;4:15040. doi: 10.1038/boneres.2015.40. eCollection 2016.</citation>
      </article>
      <article>
        <ref-id>A19159</ref-id>
        <pubmed-id>14996869</pubmed-id>
        <citation>Knutsen G, Engebretsen L, Ludvigsen TC, Drogset JO, Grontvedt T, Solheim E, Strand T, Roberts S, Isaksen V, Johansen O: Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am. 2004 Mar;86-A(3):455-64.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>Cellular repair strategy for patients with symptomatic cartilage defects of the femoral condyle (medial, lateral or trochlea) caused by trauma or patients who were previously unresponsive to available surgical procedures. </indication>
  <pharmacodynamics>Autologous cultured chrondrocytes reduce pain and considerably improve function in patients with defected cartilage at femoral joints by producing hyaline-like cartilage repair tissue. </pharmacodynamics>
  <mechanism-of-action>Chrondrocytes are collected from the patient's femoral articular cartilage and isolated cells are expanded through cell culture in vitro. Multiplied chrondrocytes are implanted into articular cartilage defects beneath an autologous periosteal flap. Cells produce hyaline-like cartilage that mainly consists of type II collagen. Type II collagen maintain the macromolecular framework in the extracellular matrix that gives integrity to surrounding hyaline cartilage. The therapy repairs damaged cartilage and restores functional and mechanical ability to withstand compressional, tensile, and shear forces.</mechanism-of-action>
  <toxicity>Unwanted effects from therapy include arthrofibrosis/joint adhesions, graft overgrowth, chondromalacia or chondrosis, cartilage injury, graft complication, meniscal lesion and graft delamination in less than 5% of total patients who underwent treatment. </toxicity>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms/>
  <products>
    <product>
      <name>Carticel</name>
      <labeller>Genzyme Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>58468-1025</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-08-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Implant</dosage-form>
      <strength>1.2e+007 1/1</strength>
      <route>Intra-articular</route>
      <fda-application-number>BLA103661</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Carticel</name>
      <labeller>Vericel Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>69866-1025</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1905-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Implant</dosage-form>
      <strength>1.2e+007 1/1</strength>
      <route>Intra-articular</route>
      <fda-application-number>BLA103661</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Maci</name>
      <labeller>Vericel Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>69866-1030</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-01-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Implant</dosage-form>
      <strength/>
      <route>Intra-articular</route>
      <fda-application-number>BLA125603</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Carticel</name>
      <ingredients>Autologous cultured chondrocytes</ingredients>
    </mixture>
    <mixture>
      <name>Carticel</name>
      <ingredients>Autologous cultured chondrocytes</ingredients>
    </mixture>
    <mixture>
      <name>Maci</name>
      <ingredients>Autologous cultured chondrocytes + Pork Collagen</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Autologous Cultured Cell</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Implant</form>
      <route>Intra-articular</route>
      <strength>1.2e+007 1/1</strength>
    </dosage>
    <dosage>
      <form>Implant</form>
      <route>Intra-articular</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <fda-label>//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB10997.pdf?1457727589</fda-label>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347911074</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Autologous_chondrocyte_implantation</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>RxList</resource>
      <url>http://www.rxlist.com/carticel-drug.htm</url>
    </external-link>
    <external-link>
      <resource>Drugs.com</resource>
      <url>http://www.drugs.com/pro/carticel.html</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>